发明名称 SELECTIVE KINASE INHIBITORS
摘要 Provided are pyrimidine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibition Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.
申请公布号 US2014323418(A1) 申请公布日期 2014.10.30
申请号 US201214360203 申请日期 2012.11.23
申请人 PORTOLA PHARMACEUTICALS, INC. 发明人 Jia Zhaozhong J.;Kane Brian;Xu Qing;Bauer Shawn M.;Song Yonghong;Pandey Anjali;Dick Ryan
分类号 C07D239/48;C07D403/14;C07H15/26;C07D401/14;C07D413/12;C07D495/04;C07D471/04;C07D405/12;C07D405/14;C07D417/14;C07D403/12;C07D417/12 主分类号 C07D239/48
代理机构 代理人
主权项 1. A compound of Formula (I):or a pharmaceutically acceptable salt thereof, wherein W is selected from the group consisting of (a) C3-8cycloalkyl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of C1-8 alkyl, amino, hydroxy, C1-8alkylcarbonyl, aminocarbonyl, C1-8alkoxycarbonylamino, arylC1-8alkoxycarbonylamino, aryl and heterocyclylC1-8alkylene; (b) C1-8 alkyl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of amino, oxo, C1-8alkoxy, C2-8alkynyl, cyano, aminocarbonyl, C1-8haloalkylene, hydroxy, halogen, C3-8cycloalkyl, and aryl; (c) C1-8 alkylC3-8heterocyclyl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of C1-8alkyl, C1-8alkylcarbonyl, C1-8alkylsulfonyl; and aminocarbonyl; (d) aryl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of C1-8alkyl, C2-8alkenyl, C2-8alkynyl, C1-8haloalkylene, carboxy, acyl, acylamino, cyano, amino, aminocarbonyl, aminosulfonyl, sulfonyl, nitro, hydroxy, C1-8alkoxy, aryloxy, halo, sulfonylamino, C3-8cycloalkyl, aryl, heterocyclyl C1-8alkylsulfonyl, C1-8alkylcarbonylheterocyclyl and heteroaryl; (e) heteroaryl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of C1-8alkyl, C1-8alkylcarbonyl, aminocarbonyl, C1-8alkoxycarbonyl, amino, C1-8 alkoxycarbonylamino, arylC1-8alkoxycarbonylamino, hydroxy, C1-8 alkoxy, C1-8alkylsulfonyl, oxo, halo, aryl and heterocyclylC1-8alkylene; (f) C3-8heterocyclyl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxycarbonyl and oxo; R1 is selected from the group consisting of H, C1-8 alkyl, amino, aminocarbonyl, hydroxy, C1-8 alkoxy, C1-8 haloalkylene, C2-8 alkenyl, C2-8 alkynyl, oxo, cyano, C1-8 alkoxycarbonyl, C3-8 cycloalkyl, aryl and heterocyclyl; and each heterocyclyl is optionally substituted with from 1 to 4 substituents selected from the group consisting of C1-8 alkyl, halo, oxo, amino, C1-8alkoxy, C1-8alkylcarbonyl, arylC1-8 alkoxycarbonyl, aminocarbonyl, arylC1-8 alkylenecarbonyl and C1-8 alkylsulfonyl; Y is selected from the group consisting ofand d) heterocyclyl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of C1-8alkyl, C1-8alkenyl, amino, cyanoC1-8alkylene, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, oxoC1-8alkylene, hydroxyalkyl, carboxy, haloC1-8alkylene, cyano and oxo and halo e) phenyl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of alkyl, alkoxy and halo; f) pyridyl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of alkoxy; g) indinlyl, optionally substituted with from 1 to 4 substituents independently selected from the group consisting of hydroxyl and oxo; R1a is selected from the group consisting of oxo, hydroxy, alkoxy, NH2, N3, triazinyl, HC(O)NH—, NCCH2NH—, HOCH2CH2NH—, R1uOCONH—, R1vNHCH(CH3)NH—, N+(O−) H2, N(O), N(═CH2), R1wOC(O)NH—, and C1-8alkylC(O)NH—; R1b is selected from the group consisting of H, hydroxyl, fluoro, combined to form an oxo group, or one R1b is combined with R1a to form a pyridyl ring and the other R1b is null; R1c is selected from the group consisting of H, fluoro, hydroxyl, alkoxy, benzyloxy; R1d is independently selected from H, alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, and heterocyclylcarbonyl; R1e is independently selected from H and aminocarbonyl; R1u is selected from the group consisting of H, alkyl, and heterocyclyl optionally substituted with one to four substitutents independently selected from the group consisting of oxo, hydroxy, and carboxy; R1v is a sugar moiety; R1w is a moiety of formula V attached via a covalent bond at R1a wherein Y is each R1f is selected from the group consisting of H, C1-8alkyl, C1-8haloalkylene, phenyl, C3-8cycloalkyl, hydroxyC1-8alkylene, NH2, C1-8alkylamino, C1-8 alkoxycarbonylaminoC1-8 alkylene, C3-8cycloalkylC1-8 alkylene, heteroaryl, alkylene, C1-8alkylsulfonylC1-8 alkylene, aminocarbonyl, C1-8alkoxyC1-8alkyl, haloC1-8alkylene, aryl and heterocyclyl; wherein the aryl is optionally substituted by hydroxy, C1-8alkoxy, halo or haloC1-8alkylene; R1g is independently selected from the group consisting of H, C1-8alkyl, C3-8cycloalkyl, and C3-8cycloalkylC1-8 alkylene; R1x is H, alkyl, haloalkyl or combined with R1y to form a cycloalkyl group; R1y is selected from the group consisting of H, C1-8alkyl, C1-8alkylamino, amino aminoC1-8alkylene, carboxy, C1-8alkylaminoC1-8alkylene, C1-8alkoxyC1-8alkylene, hydroxyC1-8alkylene; carboxyC1-8alkylene, C3-8cycloalkylC1-8alkylene, aryloxyC1-8alkylene, arylC1-8alkylene, heteroarylC1-8alkylene, and hydroxyC1-8alkoxy; or R1y may be combined with R1f or R1x and the atoms to which they are attached to form a C3-8 cycloalkyl or heterocyclyl ring optionally substituted with one to three groups independently selected from hydroxy, halo, oxo and amino; R1z is selected from the group consisting of H, amino, C1-8alkylamino, hydroxycarbonylamino, C1-8alkoxycarbonylamino, arylC1-8alkoxycarbonylamino and hydroxy; and the wavy line indicates the point of attachment to the rest of the molecule wherein the wavy line indicates the point of attachment to the rest of the molecule.
地址 South San Francisco CA US